Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.62 USD | -0.06% | -4.01% | +13.80% |
08/05 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
07/05 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.80% | 3.08B | |
+19.37% | 47.02B | |
+48.77% | 41.86B | |
+0.15% | 41.76B | |
-4.27% | 28.8B | |
+11.70% | 26.05B | |
-22.03% | 19.15B | |
+4.71% | 12.55B | |
+29.23% | 12.34B | |
-4.60% | 11.82B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- Wedbush Raises IDEAYA Biosciences' PT to $40 From $35 on Increased Confidence in IDE397/AMG 193 Combination, Keeps Outperform Rating